ACADIA Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACAD research report →
About the company
ACADIA Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics. Their core focus lies in addressing critical unmet medical needs within the realm of central nervous system (CNS) disorders.
- CEO
- Catherine E. Owen Adams
- IPO
- 2004
- Employees
- 653
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $4.45B
- P/E
- 11.79
- P/S
- 4.06
- P/B
- 3.55
- EV/EBITDA
- 33.22
- Div Yield
- 0.00%
- Gross Margin
- 91.47%
- Op Margin
- 7.39%
- Net Margin
- 34.30%
- ROE
- 35.65%
- ROIC
- 6.17%
- Revenue
- $1.07B · 11.87%
- Net Income
- $391.00M · 72.66%
- EPS
- $2.32 · 69.34%
- Op Income
- $104.81M
- FCF YoY
- -33.11%
- 52W High
- $28.35
- 52W Low
- $19.69
- 50D MA
- $22.14
- 200D MA
- $23.27
- Beta
- 0.83
- Avg Volume
- 1.70M
Get TickerSpark's AI analysis on ACAD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 26, 26 | Kihara James | sell | 11,421 |
| May 29, 26 | BAKER BROS. ADVISORS LP | other | 18,622 |
| May 29, 26 | BAKER BROS. ADVISORS LP | other | 18,622 |
| May 29, 26 | BAKER BROS. ADVISORS LP | other | 32,008 |
| May 29, 26 | HARRIGAN EDMUND | other | 8,107 |
| May 29, 26 | HARRIGAN EDMUND | other | 16,004 |
| May 29, 26 | HARRIGAN EDMUND | other | 9,311 |
| May 29, 26 | HARRIGAN EDMUND | other | 8,107 |
| May 29, 26 | Ndu Adora | other | 8,107 |
| May 29, 26 | Ndu Adora | other | 16,004 |
Our ACAD coverage
Recent articles, reports, and earnings notes.
No research on ACAD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ACAD report →Similar companies
Peers in the same neighborhood.